Aug 2026· Virulence· Vol 17· 0 citations· 194 references
Medicine
TL;DR
This review highlights that a systematic understanding of HSV-1-induced immunometabolic dysregulation reveals novel therapeutic targets, and offers a promising precision medicine approach against HSV-1 infection and related pathologies.
Abstract
ABSTRACT Herpes Simplex Virus Type 1 (HSV-1) strategically reprograms host cell metabolism to fulfill its replicative needs and establish persistent infection. This hijacking extends across glucose, lipid, amino acid, and nucleotide pathways, diverting resources toward viral biosynthesis. Critically, the resulting metabolic landscape is not neutral but actively immunosuppressive. By altering the availability of key metabolites and cellular energy states, HSV-1 impairs the function of innate and adaptive immune cells, including antigen presentation by dendritic cells and the effector response of T cells, thereby enabling immune evasion. This review highlights that a systematic understanding of HSV-1-induced immunometabolic dysregulation reveals novel therapeutic targets. Exploiting these metabolic vulnerabilities – through pharmacological intervention or engineered oncolytic viruses – offers a promising precision medicine approach against HSV-1 infection and related pathologies.
ABSTRACT Gene therapy has emerged as a promising strategy for cancer treatment, yet challenges in efficient gene delivery remain a major barrier. Herpes simplex virus type 1 (HSV-1), as an oncolytic virus, has garnered attention for its potential in cancer therapy due to its replicative capacity, large genomic payload,...
These findings identify natural-product scaffolds with high potential to modulate UL21-mediated immune suppression, with kaempferol 3,7,4′-tri-O-β-glucoside emerging as the most promising candidate and provide a foundation for experimental validation and future antiviral drug development targeting HSV-1.
Muhammad Suleman, Imtiaz Ali, A. M. Sayaf et al.· PLoS ONE· 0 citations
The DNA damage response (DDR) network maintains genomic integrity, functions as a signaling hub that viruses exploit to drive pathogenesis, and constitutes a central interface between viral infection and host cell fate. This review discusses the molecular mechanisms by which viruses subvert host DDR pathways, with an e...
Influenza virus infection remains a leading cause of acute respiratory illness worldwide, with increasing resistance to conventional antiviral therapies highlighting the need for novel therapeutic strategies. This review introduces the concept of metabolizeaccretion, a self-reinforcing pathological cascade driven by me...
Ke-Xin Wang, Yue-Peng Li, Xiao-Hong Chen et al.· Pharmacology and Therapeutic...· 0 citations
Abstract Many viruses manipulate the host cell cycle to enhance viral replication and promote their evasion of host immune defenses. Human immunodeficiency virus type 1 (HIV-1) is no exception and triggers cell cycle arrest during its infection of replicating CD4+ T cells, acting predominantly through the activities of...
Madison Bandini, N. Sherer· Biochemical Society Transact...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.